Cargando…

Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress

PURPOSE: Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables that has therapeutic efficacy in numerous animal models of human disease, including mouse models of retinal degeneration. However, despite dozens of clinical trials, the compound remains to be tested as a clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xiaoping, Walton, Dorothy A., Plafker, Kendra S., Boulton, Michael E., Plafker, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603948/
https://www.ncbi.nlm.nih.gov/pubmed/36338670
_version_ 1784817685963472896
author Qi, Xiaoping
Walton, Dorothy A.
Plafker, Kendra S.
Boulton, Michael E.
Plafker, Scott M.
author_facet Qi, Xiaoping
Walton, Dorothy A.
Plafker, Kendra S.
Boulton, Michael E.
Plafker, Scott M.
author_sort Qi, Xiaoping
collection PubMed
description PURPOSE: Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables that has therapeutic efficacy in numerous animal models of human disease, including mouse models of retinal degeneration. However, despite dozens of clinical trials, the compound remains to be tested as a clinical treatment for ocular disease. Numerous cellular activities of SFN have been identified, including the activation of Nrf2, a transcription factor that induces a battery of target gene products to neutralize oxidative and xenobiotic stresses. As Nrf2 expression and function reportedly decrease with aging, we tested whether the loss of the transcription factor limits the therapeutic efficacy of SFN against retinal degeneration. METHODS: Six- to 8-month-old wild-type and Nrf2 knockout mice were treated with SFN beginning 1 month after ribozyme-mediated knockdown of superoxide dismutase 2 (SOD2) mRNA in the RPE. The impacts of MnSOD (the protein product of SOD2) knockdown and the efficacy of SFN were evaluated using a combination of electroretinography (ERG), spectral domain optical coherence tomography (SD-OCT), and postmortem histology. RESULTS: SFN restored the ERG photopic b-wave suppressed by MnSOD loss in wild-type mice, but not in the Nrf2 knockout mice. In contrast, ERG scotopic a- and b-wave loss was not restored for either genotype. SFN significantly improved retinal thickness in the Nrf2 knockout mice with MnSOD knockdown, but this was not observed in the wild-type mice. In both genotypes, SFN treatment reduced morphological markers of RPE atrophy and degeneration, although these improvements did not correlate proportionally with functional recovery. CONCLUSIONS: These findings highlight the capacity of SFN to preserve cone function, as well as the potential challenges of using the compound as a standalone treatment for age-related retinal degeneration under conditions associated with reduced Nrf2 function.
format Online
Article
Text
id pubmed-9603948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-96039482022-11-03 Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress Qi, Xiaoping Walton, Dorothy A. Plafker, Kendra S. Boulton, Michael E. Plafker, Scott M. Mol Vis Research Article PURPOSE: Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables that has therapeutic efficacy in numerous animal models of human disease, including mouse models of retinal degeneration. However, despite dozens of clinical trials, the compound remains to be tested as a clinical treatment for ocular disease. Numerous cellular activities of SFN have been identified, including the activation of Nrf2, a transcription factor that induces a battery of target gene products to neutralize oxidative and xenobiotic stresses. As Nrf2 expression and function reportedly decrease with aging, we tested whether the loss of the transcription factor limits the therapeutic efficacy of SFN against retinal degeneration. METHODS: Six- to 8-month-old wild-type and Nrf2 knockout mice were treated with SFN beginning 1 month after ribozyme-mediated knockdown of superoxide dismutase 2 (SOD2) mRNA in the RPE. The impacts of MnSOD (the protein product of SOD2) knockdown and the efficacy of SFN were evaluated using a combination of electroretinography (ERG), spectral domain optical coherence tomography (SD-OCT), and postmortem histology. RESULTS: SFN restored the ERG photopic b-wave suppressed by MnSOD loss in wild-type mice, but not in the Nrf2 knockout mice. In contrast, ERG scotopic a- and b-wave loss was not restored for either genotype. SFN significantly improved retinal thickness in the Nrf2 knockout mice with MnSOD knockdown, but this was not observed in the wild-type mice. In both genotypes, SFN treatment reduced morphological markers of RPE atrophy and degeneration, although these improvements did not correlate proportionally with functional recovery. CONCLUSIONS: These findings highlight the capacity of SFN to preserve cone function, as well as the potential challenges of using the compound as a standalone treatment for age-related retinal degeneration under conditions associated with reduced Nrf2 function. Molecular Vision 2022-10-16 /pmc/articles/PMC9603948/ /pubmed/36338670 Text en Copyright © 2022 Molecular Vision. https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Qi, Xiaoping
Walton, Dorothy A.
Plafker, Kendra S.
Boulton, Michael E.
Plafker, Scott M.
Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title_full Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title_fullStr Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title_full_unstemmed Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title_short Sulforaphane recovers cone function in an Nrf2-dependent manner in middle-aged mice undergoing RPE oxidative stress
title_sort sulforaphane recovers cone function in an nrf2-dependent manner in middle-aged mice undergoing rpe oxidative stress
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603948/
https://www.ncbi.nlm.nih.gov/pubmed/36338670
work_keys_str_mv AT qixiaoping sulforaphanerecoversconefunctioninannrf2dependentmannerinmiddleagedmiceundergoingrpeoxidativestress
AT waltondorothya sulforaphanerecoversconefunctioninannrf2dependentmannerinmiddleagedmiceundergoingrpeoxidativestress
AT plafkerkendras sulforaphanerecoversconefunctioninannrf2dependentmannerinmiddleagedmiceundergoingrpeoxidativestress
AT boultonmichaele sulforaphanerecoversconefunctioninannrf2dependentmannerinmiddleagedmiceundergoingrpeoxidativestress
AT plafkerscottm sulforaphanerecoversconefunctioninannrf2dependentmannerinmiddleagedmiceundergoingrpeoxidativestress